Objective: To test the efficacy and tolerability of the methylphenidate transdermal formulation (MTS) against immediate-release methylphenidate (IR MPH) and placebo in a 12-hr analog classroom setting. Method: A total of nine boys ages 6 to 9 years, medicated with MPH for ADHD, complete a within-subject, double-blind study. For the purpose of the study, the boys are administered a dose of 20 cm2 MTS, a matched dose of IR MPH 10 mg TID, and placebo. ADHD symptoms and frequency counts of classroom rule violations and the number of math problems completed are assessed hourly, during three consecutive analog classroom sessions. Results: Findings show that, across measures and throughout the day, both treatments significantly differentiated from placebo (p < .05) but not from each other. It is also observed that the MTS produced more consistent results across the day but had a delayed onset versus IR MPH. Both medications are well tolerated with only mild reductions in sleep onset. Conclusion: The MTS demonstrates comparable efficacy and tolerability to TID IR MPH.
Daytrana [package insert]. Wayne, PA; Shire US Inc; 2009.
2.
Findling, R.L., Bukstein, O.G., Melmed, R.D., Lopez, F.A., Sallee, F.R., Arnold, L.E., et al. (2008). A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention deficit hyperactivity disorder. Journal of Clinical Psychiatry, 69, 149-159.
3.
Gau, S.F., Shen, H.Y., Chou, M.C., Tang, C.S., Chiu, Y.N., & Gau, C.S. ( 2006). Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. Journal of Child and Adolescent Psychopharmacology, 16, 286-297.
4.
Loney, J., & Milich, R. ( 1982). Hyperactivity, inattention, and aggression in clinical practice. In M. Wolraich & D. K. Routh (Eds.), Advances in developmental and behavioral pediatrics (pp. 113-147). Greenwich, Conn: JAI Press.
5.
McGough, J.J., Wigal, S.B., Abikoff, H., Turnbow, J.M., Posner, K., & Moon, E. ( 2006). A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with attention deficit hyperactivity disorder. Journal of Attention Disorders, 9, 476-485.
6.
Muniz, R., Brams, M., Mao, A., McCague, K., Pestreich, L., & Silva, R. ( 2008). Efficacy and safety of extended-release demethylphendiate compared with d, l-mehtyphenidate and placebo in the treatment of children with attention deficit hyperactivity disorder: A 12 hour laboratory classroom study. Journal of Child and Adolescent Psychopharmacology , 18, 248-256.
7.
Pelham, W.E., Burrows-MacLean, L., Gnagy, E.M., Fabiano, G.A., Coles, E.K., Tresco, K.E., et al. (2005). Transdermal methylphenidate, behavioral, and combined treatment for children with attention deficit hyperactivity disorder . Experimental and Clinical Psychopharmacology, 13, 111-126.
8.
Pelham, W.E., Carlson, C.L., Sams, S.E., Vallano, G., Dixon, M.J., & Hoza, B. ( 1993). Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit hyperactivity disorder in the classroom. Journal of Consulting and Clinical Psychology , 61, 506-515.
9.
Pelham, W.E., Gnagy, E.M., Burrows-MacLean, L., Williams, A., Fabiano, G.A., Morrisey, S.M., et al. (2001). Once-a-day concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics, 107, e105.
10.
Pelham, W.E., Gnagy, E.M., Greenslade, K.E., & Milich, R. ( 1992). Teacher ratings of DSM IIIR symptoms for the disruptive behavior disorders. Journal of American Academy of Child and Adolescent Psychiatry, 31, 210-218.
11.
Pelham, W.E., Manos, M.J., Ezzell, C.E., Tresco, K.E., Gnagy, E.M., Hoffman, M.T., et al. (2005). A dose ranging study of a methylphenidate transdermal system in children with attention deficit hyperactivity disorder . Journal of American Academy of Child and Adolescent Psychiatry , 44, 522-529.
12.
Pelham, W.E., Massetti, G.M., & Fabiano, G.A. ( 2005). Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. Journal of Clinical Child & Adolescent Psychology, 34, 449-476.
13.
Pierce, D., Dixon, C., Wigal, S., & McGough, J. ( 2008). Pharmacokinetics of methylphenidate trasndermal system (MTS): Results from a laboratory classroom study. Journal of Child and Adolescent Psychopharmacology, 18, 355-364.
14.
Pliszka, S. ( 2007). AACAP-Work-Group-on-Quality-Issues Practice parameter for the assessment and treatment of children and adolescents with attention deficit/hyperactivity disorder. Journal of American Academy of Child and Adolescent Psychiatry, 46, 894-921.
15.
Shaffer, D., Fisher, P., Lucas, C.P., Dulcan, M.K., & Schwab-Stone, M.E. (2000). NIMH diagnostic interview schedule for children version IV (NIMH DISC-IV): Description, differences from previous versions, and reliability of some common diagnoses. Journal of Ameican Academy of Child and Adolescent Psychiatry, 39, 28-38.
16.
Steele, M., Weiss, M., Swanson, J., Wang, J., Prinzo, R.S., & Binder, C.E. ( 2006). A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit hyperactivity disorder. Canadian Journal of Clinical Pharmacology, 13, e50-62.
17.
Swanson, J., Lerner, M., Wigal, T., Steinhoff, K., Greenhill, L., Posner, K., et al. (2002). The use of laboratory school protocol to evaluate conecpts about the efficiacy and side effects of new formulations of stimulant medications. Journal of Attention Disorders, 6, S73-88.
18.
Swanson, J., Wigal, S., Wigal, T., Sonuga-Barke, E., Greenhill, L., Biederman, J., et al. (2004). COMACS Study Group. A comparison of once-daily extended-release methylphenidate formulations in children with attention deficit hyperactivity disorder in the laboratory school (The Comacs Study). Pediatrics, 113, e206-216.
19.
Waschbusch, D., Pelham, W., Waxmonsky, J., & Johnson, C. ( 2009). Are there placebo effects in the medication treatment of children with ADHD?Journal of Developmental and Behavioral Pediatrics, 30, 158-168.
20.
Wechsler, D. ( 1991). Wechsler Intelligence Scale for Children- Third Edition. New York: Psychological Corporation .
21.
Weisler, R.H. ( 2007). Review of long acting stimulants in the treatment of attention deficit hyperactivity disorder. Expert Opinion on Pharmacotherapy, 8, 745-758.
